SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-19-000149
Filing Date
2019-02-15
Accepted
2019-02-14 18:43:33
Documents
2
Group Members
ROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A auris_13ga1.htm SC 13G/A 106485
2 EXHIBIT A ex_a.htm EX-99.A 7261
  Complete submission text file 0001019056-19-000149.txt   115634
Mailing Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000
Business Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000 41 (0)61 201 13 50
Auris Medical Holding AG (Subject) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88281 | Film No.: 19609117
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13G/A